ICU Medical, Inc. ICUI
182.11 USD +3.26 (+1.82%)
At closeNov 11, 2026, 4:19 AM EST
182.62 +0.51 +0.28%
Pre-market · Nov 11, 4:19 AM ET
176.86 Day range 183.03
113.37 52-week range 192.85
- YTD
- +27.64%
- 1 year
- +30.80%
News
benzinga.com Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $189 Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $187 to $189.
benzinga.com Piper Sandler Maintains Overweight on ICU Medical, Raises Price Target to $200 Piper Sandler analyst Jason Bednar maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $195 to $200.
globenewswire.com ICU Medical to Present at the 2026 Jefferies Global Healthcare Conference in London SAN CLEMENTE, Calif., Nov. 06, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that…
marketbeat.com ICU Medical Q3 Earnings Call Highlights ICU Medical NASDAQ: ICUI reported third-quarter revenue of $556 million and said it expects full-year adjusted earnings to finish toward the high end of its existing guidance, as growth in infusion…
zacks.com ICU Medical (ICUI) Beats Q3 Earnings and Revenue Estimates ICU Medical (ICUI) came out with quarterly earnings of $2.44 per share, beating the Zacks Consensus Estimate of $2.14 per share. This compares to earnings of $2.03 per share a year ago.
zacks.com ICU Medical (ICUI) Reports Q3 Earnings: What Key Metrics Have to Say The headline numbers for ICU Medical (ICUI) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street…
seekingalpha.com ICU Medical, Inc. (ICUI) Q3 2026 Earnings Call Transcript ICU Medical, Inc. (ICUI) Q3 2026 Earnings Call Transcript
benzinga.com ICU Medical Q3 2026 Earnings Call Transcript ICU Medical (NASDAQ:ICUI) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…- benzinga.com ICU Medical Affirms FY2026 GAAP EPS Guidance of $2.89-$3.29 vs $3.47 Est ICU Medical (NASDAQ:ICUI) affirms FY2026 GAAP EPS guidance from $2.89-$3.29 to $2.89-$3.29 vs $3.47 analyst estimate..
benzinga.com ICU Medical Affirms FY2026 Adj EPS Guidance of $8.60-$9.00 vs $8.74 Est ICU Medical (NASDAQ:ICUI) affirms FY2026 Adj EPS guidance from $8.60-$9.00 to $8.60-$9.00 vs $8.74 analyst estimate..
benzinga.com ICU Medical Q3 Adj. EPS $2.44 Beats $2.14 Estimate, Sales $560.439M Beat $552.071M Estimate ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $2.44 per share which beat the analyst consensus estimate of $2.14 by 14.02 percent. This is a 20.2 percent increase over earnings of $2.03…
globenewswire.com ICU Medical Announces Third Quarter 2026 Results and Reaffirms Fiscal Year 2026 Guidance, Expecting Results at the High End of Range SAN CLEMENTE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial…